Australia's Monash University inks research collaboration with Japan-based Ono Pharma
Therapeutics | News | 0 Comment | 13 Jan, 2023
An option and research collaboration agreement has been established between Australia's Monash University and Japan-base...Read more
Malaysian Genomics explores R&D collaboration with SIRIM
Therapeutics | News | 0 Comment | 10 Jan, 2023
Malaysian Genomics Resource Centre Berhad , a leading genomics and biopharmaceutical specialist, has announced a s...Read more
First made-in-Singapore antibody-drug conjugate to enter clinical trials
Therapeutics | News | 0 Comment | 09 Jan, 2023
Singapore’s drug discovery efforts have reached a new milestone as EBC-129, the first made-in-Singapore antibody-d...Read more
“We are seeing activity within biotherapeutics market in Southeast Asia”
Therapeutics | Opinion | 4 Comment | 06 Jan, 2023
With biomarkers and biotherapeutics gaining significant attention in 2022, BioSpectrum spoke in detail with Jason Neo (R...Read more
US explores application of 3D bioprinting to create eye tissue
Therapeutics | News | 1 Comment | 26 Dec, 2022
Scientists are now using patient stem cells and 3D bioprinting to produce eye tissue that will advance understanding of ...Read more
Australian first research trial to explore use of psychedelics for alcohol use disorder
Therapeutics | News | 0 Comment | 22 Dec, 2022
Researchers at the University of Sydney are embarking on an Australian first research trial into the use of psychedeli...Read more
Singapore identifies new therapeutic target for treating diabetic eye disease
Therapeutics | News | 0 Comment | 23 Dec, 2022
Singapore researchers have discovered a novel therapeutic target named ADAM10 that could be used to treat patients ...Read more
Researchers at Australia & Korea investigate effect of COVID-19 virus on vision
Therapeutics | News | 0 Comment | 20 Dec, 2022
A study, co-led by Australia-based Griffith University’s Menzies Health Institute and South Korea’s Center f...Read more
Singapore identifies predictive blood biomarker for cognitive impairment and dementia
Therapeutics | News | 0 Comment | 21 Dec, 2022
A recent study by a team comprising researchers from the National University of Singapore (NUS) and the National Univers...Read more
Hong Kong develops new aptamer drug for bone anabolic therapies
Therapeutics | News | 0 Comment | 19 Dec, 2022
A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone amabolic therapies...Read more
Japanese firm Eisai partners with Washington University for treatment of neuro diseases
Therapeutics | News | 0 Comment | 19 Dec, 2022
Eisai and Washington University School of Medicine in St. Louis have entered into a comprehensive research collaboration...Read more
Trial of ultrasound treatment for Alzheimer’s underway in Australia
Therapeutics | News | 0 Comment | 13 Dec, 2022
A pioneering treatment for Alzheimer’s disease, developed at The University of Queensland (UQ) in Australia, is be...Read more
Singapore identifies gene that controls scarring in damaged hearts
Therapeutics | News | 0 Comment | 12 Dec, 2022
Scientists at Duke-NUS Medical School in Singapore have identified a gene that controls the behaviour of a specific type...Read more
Hong Kong develops multifunctional nanoparticle for diagnosis & treatment of glioma
Therapeutics | News | 0 Comment | 28 Nov, 2022
A Hong Kong Baptist University (HKBU) collaborative research team, along with researchers at Hong Kong Polytechnic ...Read more
Integrated stem cell solutions to combat rising degenerative diseases amongst Malaysians
Therapeutics | News | 0 Comment | 25 Nov, 2022
According to the Department of Statistics Malaysia (DOSM), population with age 60 and above is increasing yearly and Mal...Read more
Korea inks MoU with US to establish precision medicine research platform
Therapeutics | News | 0 Comment | 17 Nov, 2022
Seoul National University (SNU) Bundang Hospital Biomedical Research Institute has concluded a Memorandum of Understandi...Read more
GSK invests S$44 M in manufacturing facility at Singapore for cancer treatment
Therapeutics | Company results | By Hithaishi C Bhaskar | 9 Comment | 17 Nov, 2022
The global biopharma company GSK plc has launched a new, S$44 million high potency facility (HPF) in its strategic New P...Read more
Australia announces world first regulatory approval for donor derived microbiome drug
Therapeutics | News | 0 Comment | 09 Nov, 2022
Australian startup BiomeBank has announced the first regulatory approval for a donor derived microbiome drug product wor...Read more